soul trial oral semaglutide cardiovascular outcomes trial Trial: Reduces Events in T2DM Patients | Stanley M. Samusodza, MD, MScSM posted on the topic SOUL: Oral Semaglutide Cuts CV

There are conflicting reports about how long vitamin C from an infusion stays in your body

Phase 3 clinical trials indicate that people lost 28.3% of their body weight after 80 weeks on 12 mg of retatrutide, with 45% losing 30% or more of their weight

Its anybodys guess whats really happening with the quality control of these unregulated peptides. The products marketed as BPC-157 are, according to the systematic review, unregulated for quality and safety. You know, minor details

Starting with a lower dose and gradually increasing (a strategy already used with Wegovy and Mounjaro) helped reduce these effects

UHC and most other commercial insurers do not cover compounded GLP-1 medications because they are not FDA-approved finished products